baber/WOPTO huggingface dataset:
Patent AU-683147-B2 (AU)
Title: New peptides derived from trifluoromethylketones, process for their preparation and the pharmaceutical compositions which contain them
Inventor: NANTEUIL GUILLAUME DE
IPC: C07K5/087
Filed: 1995-05-03
Granted: 1997-10-30
Abstract: Peptide derivatives of trifluoromethyl ketones of formula (I), their hydrates, enantiomers, diastereoisomers, epimers, and salts are new. R1, R2 = 1-6C alkyl or 3-7C cycloalkyl; R3 = H, 1-6C alkyl or 3-7C cycloalkyl; R4 = halo, or 1-6C alkyl or alkoxy; R5 = 1-6C alkyl; X, Y = CO or SO2; n = 1, 2, or 3; p = 0 or 1; Z = S or O; A = a gp. of formula (i) or -NR6-CHR7-; A1 with the N and CH forms a 2-azabicyclo(2,2,2)octane, 2-aza bicyclo(2,2,1)heptane, perhydroindole, perhydroisoindole, indoline, isoindoline, perhydroquinoline, perhydroisoquinoline, 1,2,3,4-tetrahydroisoquinoline, 1,2,3,4-tetrahydroquinoline, cyclopenta(b)pyrrolidine, 1,3-thiazolidine, or pyrrolidine ring, R6 = H, 1-6C alkyl, 3-6C cycloalkyl, or indan-2-yl, R7 = H, or 1-6C alkyl.
Patent AU-712758-B2 (AU)
Title: Industrial safety glasses
Inventor: WIEDNER KLAUS
IPC: A61F9/02
Filed: 1997-04-14
Granted: 1999-11-18
Abstract: In industrial safety glasses comprising a one-piece plastics sight piece and a top of comparatively soft plastics on the forehead side which can be fixed to the sight piece and has a groove open toward the sight piece, it is provided, with a view to simple producibility, reliable arresting of the top and reliable protection of the user's eyes, that the top is injection-molded on the sight piece.
Patent AU-616672-B2 (AU)
Title: Growth hormone receptor
Inventor: HAMMONDS R GLENN
IPC: G01N33/74
Filed: 1988-06-10
Granted: 1991-11-07
Abstract: Growth hormone receptor and growth hormone binding protein are purified enabling amino acid sequence and DNA isolates coding for growth hormone receptor and growth hormone binding protein and methods of obtaining such DNA are provided, together with expression systems for recombinant production of growth hormone receptor and growth hormone binding protein. Therapeutically useful forms of the growth hormone receptor and growth hormone binding protein and anti-receptor antibodies are described.
Patent AU-656205-B2 (AU)
Title: Rotor flap apparatus
Inventor: MALVESTUTO FRANK S JR
IPC: B64C3/14
Filed: 1992-04-09
Granted: 1995-01-27
Abstract: A rotor flap apparatus is attached to the trailing edge of a wing of a craft. The rotor flap apparatus includes a rotatable rotor mounted on an attachment arm, which is pivotally mounted on a trailing edge of the wing. The attachment arm can be raised or lowered to move the plane of the rotor up or down to vary the lift and thrust characteristics of the wing, to prevent stall and also to allow very low speed take off and landing. In one embodiment, propellers are provided at the leading edge of the wing, in conjunction with the rotor flap apparatus, to provide a system which allows vertical take off and landing of the aircraft. Other embodiments include wings with rotor flap apparatus attached to land craft and underwater craft as well.
Patent AU-559224-B2 (AU)
Title: Determination of explosivity rate of gaseous medium
Inventor: BOUTONNAT MAURICE
IPC: G01N25/54
Filed: 1983-12-12
Granted: 1987-02-26
Abstract: A method and a device for determining explosivity rate of a gaseous medium with a detecting filament which is heated in said medium by an electric current flowing therethrough. Said detecting filament is ignited through connection to a power supply and power supplied to said filament is regulated so as to maintain constant the resistance thereof. At some successive moments value of a quantity U significant for power supplied to said filament is taken into account. An exponential curve is extrapolated from such values; parameters thereof are identified and introduced in a process function adapted to deduce therefrom an estimation of the initial explosivity rate of said gaseous medium independently of the nature of the explosive gas(es) present therein.
Patent AU-560420-B2 (AU)
Title: Phenoxymethyl pyridine derivatives
Inventor: TOTHT EDIT
IPC: C07D213/30
Filed: 1983-12-23
Granted: 1987-04-09
Abstract: The invention relates to new pyridne derivatives of the formula (I)   <CHEM>  wherein R1 and R2 independently represent hydrogen, halogen, trihalomethyi, alkyi having from one to 4 carbon atoms or alkoxy having from one to 4 carbon atoms, and acid addition and quaternary ammonium salts thereof. According to another aspect of the invention there are provided processes for the preparation of these compounds. The compounds of the formula (I) are pharmacologically active. In particular, they inhibit the microsomal monooxigenase enzyme system of the liver. Pharmaceutical compositons containing them as active ingredient are also within the scope of the invention.
Patent AU-656215-B2 (AU)
Title: Coding and decoding device for time-varying image
Inventor: KATO MOTOKI
IPC: H04N19/12
Filed: 1992-07-16
Granted: 1995-01-27
Abstract: A coding and decoding device for a time-varying picture, by which a high picture quality is obtained from a smaller amount of information than a system using only DCT coding. The efficiency of coding can be increased and the block distortion of a composite image is reduced. An image is divided into several blocks, and each block is coded. At this time discrete cosine transformation coding (DCT) and intrablock predictive composing (NTC) are switched over to each other adequately according to the property of the image pattern. When the intrablock predictive composing is executed, the predictive value and quantization width of a block are transmitted. <IMAGE>
Patent AU-724537-B2 (AU)
Title: Method for gene transfer to the central nervous system
Inventor: CHERKSEY BRUCE
IPC: A61K31/00
Filed: 1997-04-07
Granted: 2000-09-21
Abstract: The present invention relates to a method for implanting producer cells into the mammalian brain. The producer cells are engineered with a retroviral based recombinant vector encoding a tumorcidal factor or susceptibility factor that confers on tumor cells sensitivity to chemotherapeutic or radiotherapeutic agents. Prior to transplantation into the mammalian brain, the producer cells are first cultured in vitro on a support matrix to increase the long-term viability of the transplanted cells and to provide long-term functional benefit.
Patent AU-732572-B2 (AU)
Title: Method of producing a plastic pulley with a metal insert
Inventor: EMMETT KEVIN J
IPC: B29L31/32
Filed: 1999-03-09
Granted: 2001-04-26
Abstract: A method for producing a pulley assembly intended primarily for use with the endless drive belt of a vehicle accessories drive system is provided. The method involves placing a circular metal insert having an axis and an outer substantially flat circumferential surface extending radially from the axis on a locating means, located inside a mold cavity and positioned around the outside circumference of the metal insert, for positioning the metal insert inside the mold cavity before molding and for maintaining the roundness of the metal insert during molding, and molding a plastic annular body about the metal insert. A pulley assembly produced by this method is also provided. The method of producing the pulley assembly may include modifying the outer flat circumferential surface of the metal insert prior to molding the plastic annular body about the metal insert, for clamping, structurally bonding, and resisting relative rotation between the plastic body and the metal insert.
Patent AU-659980-B2 (AU)
Title: Method for allocating time slots for transmission in a half-duplex time division multiple access point-to-multipoint bidirectional transmission network
Inventor: MARCEL FRANCOIS
IPC: H04J3/00
Filed: 1993-01-28
Granted: 1995-06-01
Abstract: According to this method, the time of origin (t''2) of the upgoing frames being, in every remote station, chosen in such a way that, in the central station, the time (t'2) of origin of these frames is separated from the time (t'1) of the end of the downgoing frames by a period less than To, where To denotes twice the time of propagation between this remote station and the central station, thus defining, in the said remote station, a region of so-called overlap between downgoing and upgoing frames, the said time slot assignment is effected so as to avoid any coincidence of assigned time slots, at any one remote station, in the upgoing and downgoing frames respectively, in the said region of overlap. <IMAGE>
Patent AU-617788-B2 (AU)
Title: Apparatus and method for a secure and diagnosable antijabber communication circuit
Inventor: GERHART PAUL B
IPC: H04Q9/00
Filed: 1988-11-16
Granted: 1991-12-05
Abstract: In order to prevent 'jabber', the uncontrolled transmission of messages on a communication channel, an antijabber timing unit is frequently used to determine whether a message on the communication channel exceeds the maximum permitted length of time. The present invention provides testing apparatus to determine when the antijabber timing unit is functioning accurately. In addition, protection is provided so that the testing apparatus does not compromise the function of the antijabber timing unit during subsequent message transmission. The antijabber timing unit is also used as part of the enable function for the transmission of messages over a channel to prevent the failure of a single component from resulting in inadvertent transmission of information.
Patent AU-634961-B2 (AU)
Title: Detection, quantitation and classification of ras proteins in body fluids and tissues
IPC: C07K16/32
Filed: 1989-04-20
Granted: 1993-03-11
Abstract: The subject of this invention is the detection, quantitation of ras p21 proteins in body fluids, tissues, or cells. Specifically, this invention concerns detecting and quantitating normal and mutated ras p21s from normal subjects, subjects suspected of having preneoplastic disease or subjects known or suspected of having neo-plastic (cancer) disease. This invention also concerns the detection and quantitation of the ras p21 proteins into the three families of ras proteins designated Ha, Ki and N in body fluids and tissues. <IMAGE>
Patent AU-773675-B2 (AU)
Title: Method for analyzing the amount of intraabdominal adipose tissue
Inventor: MATSUZAWA YUJI
IPC: G01N33/68
Filed: 2000-04-06
Granted: 2004-06-03
Abstract: The present invention provides a method for analyzing the amount of intraabdominal adipose tissue comprising:determining the amount of intraabdominal tissue in a test-animal from the concentration of a protein in a body fluid, tissue or cell of said test-animal or in a prepared test solution from the body fluid, tissue or cell of said test-animal, based on the positive relationship between the amount of the intraabdominal adipose tissue in an animal and the concentration of a protein in a body fluid, tissue or cell of said animal or in a prepared solution from the body fluid, tissue or cell of said animal,wherein the protein is (1) encompassed by the amino acid sequence shown in SEQ ID NO:1 or is (2) recognized by an antibody against a protein encompassed by the amino acid sequence shown in SEQ ID NO:1.
Patent AU-691711-B2 (AU)
Title: Fluidized bed type reduction apparatus for iron ores and method for reducing iron ores using the apparatus
Inventor: LEE IL OCK
IPC: C21B13/14
Filed: 1995-12-28
Granted: 1998-05-21
Abstract: PCT No. PCT/KR95/00181 Sec. 371 Date Oct. 28, 1996 Sec. 102(e) Date Oct. 28, 1996 PCT Filed Dec. 28, 1995 PCT Pub. No. WO96/21044 PCT Pub. Date Jul. 11, 1996A three-stage, fluidized-bed-type reduction apparatus and a method for using it for reducing fine iron ores of wide size ranges, improving the gas utilization and reduction degree, reducing the residence time of iron ores, and increasing the prereduction rate of reduced iron. The apparatus includes serially arranged a drying/preheating furnace with a first cyclone connected to it, a primary prereduction furnace with a second cyclone connected to it, a secondary high-gas-velocity reduction furnace for finally reducing only a coarse ore portion of the prereduced iron ores at a bubbling fluidized state while carrying over the medium/fine ore portion of the iron ores, a secondary low-gas-velocity reduction furnace for finally reducing the medium/fine ores forming a bubbling fluidized bed thereof, an inner cyclone installed in the secondary low-gas-velocity reduction furnace, and a third cyclone for capturing dusty ores not captured by the inner cyclone.
Patent AU-758496-B2 (AU)
Title: Seeding crystals for the preparation of peptides or proteins
Inventor: MANIQUE FLEMMING
IPC: C30B29/58
Filed: 1999-06-30
Granted: 2003-03-20
Abstract: A method for producing seeding microcrystals for the production of human insulin, said microcrystals being free of non-human pancreatic insulin, the method comprising providing an unseeded suspension of human insulin, said suspension being free of non-human pancreatic insulin, and homogenising said insulin suspension under pressure to result in human insulin microcrystals suitable for use as seeding microcrystals for the production of zinc insulin products. The method of homogenisation under pressure may also be used for the production of seeding microcrystals for other peptides and proteins, in particular pharmaceutical peptides or proteins such as insulin, GLP-1, glucagon and growth hormones.
Patent AU-719190-B2 (AU)
Title: Substituted amylose as a matrix for sustained drug release
Inventor: CARTILIER LOUIS
IPC: A61K9/28
Filed: 1997-10-22
Granted: 2000-05-04
Abstract: A pharmaceutical sustained release tablet for oral administration is made of a compressed blend of at least two dry powders including a powder of a pharmaceutical drug and a powder of a sustained release matrix for the drug. The sustained release matrix is made of substituted amylose prepared by reacting, in a basic medium, amylose with an organic substituent having a reactive function that reacts with the hydroxy groups of the amylose molecule. This substituent is preferably an epoxy or halogen alkane or alcohol with such a matrix controlled and sustained release of a drug are achieved with a remarkable close-to-linear profile and a release time of from 9 to 20 hours.
Patent AU-767586-B2 (AU)
Title: Methods and compositions for the treatment of chronic lymphocytic leukemia
Inventor: NARDELLA FRANCIS A
IPC: A61K31/403
Filed: 1999-07-08
Granted: 2003-11-20
Abstract: The level of the leukemic lymphocytes in patients suffering from chronic lymphocytic leukemia (CLL) is reduced by the administration of certain indole or carbazole compounds, such as the nonsteroidal anti-inflammatory drug etodolac or related indole or carbazol compounds.
Patent AU-627855-B2 (AU)
Title: Method for packaging books
Inventor: JANHONEN VEIKKO ILMARI
IPC: B65B11/58
Filed: 1990-03-30
Granted: 1992-09-03
Abstract: The invention relates to a method for packaging books. The book(s) to be packaged are placed upon a rectangular flat cardboard sheet (11), followed by pulling over the book/books a separate plastic film or paper (17), which is transverse relative to the cardboard sheet and whose ends are fastened to the cardboard sheet to its top surfaces (14) adjacent the long edges thereof, and the ends of said cardboard sheet are folded around an article to be packaged for producing a tubular ptoective wrapping.
Patent AU-665881-B2 (AU)
Title: Switch for operating an electric device, in particular a radio remote control device
Inventor: BURCHARD THOMAS
IPC: H01H27/00
Filed: 1993-12-23
Granted: 1996-01-18
Abstract: A switch for operating an electrical apparatus has a removable key element for selecting the switch enable/inhibit position. The switch consists of a functional element (21) arranged in the housing of the electrical apparatus and of an operating element (22), which is placed on the functional element on the outside of the apparatus and coaxially with respect to the functional element, for switching on/off. According to the invention, the key element (11) is an integral component of a cap-like surface-mounted element (10) which is held such that it can be latched on the operating element (22). This results, in principle, in the key element (11) always being able to remain on the switch, especially in the enable position, while, on the other hand, it can also be pulled off and stored separately if required if the apparatus is intended to remain in its off state. <IMAGE>
Patent AU-588568-B2 (AU)
Title: Hot melt composition and process for forming the same
Inventor: CZERWINSKI RICHARD W
IPC: C08K5/10
Filed: 1986-02-11
Granted: 1989-09-21
Abstract: A thermoplastic hot melt composition comprising a polyurethane having at least one plasticizer reacted therein formed by heating a reaction system comprising at least one isocyanate having a functionality less than about 2.2, at least one long chain polyol, at least one chain extender and the at least one plasticizer at a temperature of at least about 330 DEG F, wherein said components are present in amounts sufficient to meet the following formula: 
<MATH>
 wherein
 A represents the equivalent weight of the long chain polyol x the moles thereof used;
 B represents the equivalent weight of the chain extender x the moles thereof used;
 C represents the equivalent weight of the isocyanate x the moles thereof used; and
 D represents the grams of plasticizer. A process for forming the same is also disclosed.
Patent AU-765763-B2 (AU)
Title: Monitoring methods using particle delivery methods
Inventor: KWON SUNG-YUN
IPC: G01N33/48
Filed: 1999-09-03
Granted: 2003-09-25
Abstract: Methods for sampling an analyte present in a biological system are provided. The methods entail use of particle delivery methods to obtain a sample of an analyte of interest from the system.
Patent AU-620997-B2 (AU)
Title: Acid containing isocyanate-terminated prepolymers, salt prepolymers and polymers thereof
Inventor: BARKSBY NIGEL
IPC: C08G18/10
Filed: 1990-06-22
Granted: 1992-02-27
Abstract: The present invention is directed to novel isocyanate-terminated prepolymers of carboxylic acid grafted polyethers, salts of these prepolymers and fully reacted polymers formed therefrom. More specifically, the present invention relates to reacting an ethylenically unsaturated mono-carboxylic acid with a polyether in the presence of a free radical initiator to form a graft copolymer. Acid-containing isocyanate- terminated prepolymers can then be formed by reacting the graft copolymer with an isocyanate. Salt-containing isocyanate-terminated prepolymers are prepared through the reaction between the acid-containing prepolymer and a base. Finally, polymers are formed by curing either of these isocyanate-terminated prepolymers with an isocyanate reactive material.
Patent AU-670177-B2 (AU)
Title: Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes
Inventor: BLACK LARRY JOHN
IPC: A61P35/00
Filed: 1994-03-16
Granted: 1996-07-04
Abstract: The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.
Patent AU-729702-B2 (AU)
Title: Aqueous dispersions of hydrophobic material
Inventor: HALLSTROM HANS
IPC: C08L101/00
Filed: 1998-02-03
Granted: 2001-02-08
Abstract: The invention relates to an aqueous dispersion containing a dispersant and a disperse phase containing a hydrophobic material, the dispersant comprising an anionic compound having a molecular weight less than 50,000 and being selected from carbon-containing compounds and silicon-containing compounds, and a cationic organic compound having a molecular weight less than 50,000. The invention further relates to the preparation and use of the dispersion in the production of paper. The invention also relates to a substantially water-free composition containing a hydrophobic material, an anionic compound having a molecular weight less than 50,000 and being selected from carbon-containing compounds and silicon-containing compounds, and a cationic organic compound having a molecular weight less than 50,000, as well as its use in the preparation of an aqueous dispersion.
Patent AU-631012-B2 (AU)
Title: Process for drawing off a milk sample
IPC: G01N1/20
Filed: 1990-09-25
Granted: 1992-11-12
Abstract: In the device for taking milk samples from a milk feedline (1), in order to remove any milk residues left adhering in a suction line (5) and an injection needle (6) by the previous supplier, before the current supplier takes samples, the suction line (5) and injection needle (6) are filled with milk and, after being filled completely, are emptied again by pumping the milk back into the feedline (1). The complete filling is monitored by a control means (9) which controls a hose pump (7) in such a way that only the milk quantity just necessary for filling the suction line (5) and injection needle (6) is conveyed. Not until after this filling and emptying operation is the injection needle (6) introduced into a sampling bottle (8) arranged on a liftable plate (15). A holding-down device (16, 17, 18) guarantees that the injection needle (6) is stripped off perfectly from the sampling bottle (8) during the lowering of the plate (15) at the end of the sampling operation. The apparatus is characterised by the simple method by which residual milk can be removed from the suction line and injection needle in order to prevent carry-overs. 
<IMAGE>
Patent AU-692153-B2 (AU)
Title: Type S3N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
Inventor: HILGER CHRISTOPH-STEPHAN
IPC: C07F13/00
Filed: 1994-03-29
Granted: 1998-06-04
Abstract: PCT No. PCT/DE94/00370 Sec. 371 Date Mar. 8, 1996 Sec. 102(e) Date Mar. 8, 1996 PCT Filed Mar. 29, 1994 PCT Pub. No. WO94/22492 PCT Pub. Date Oct. 13, 1994This invention relates to new bifunctional chelating agents with intermittent chalcogen atoms, pharmaceuticals containing these compounds, their use in radiodiagnostics and radiotherapy, and methods for the production of these compounds. The compound according to the invention has the general formula (I) M-L wherein M represents a radionuclide of Tc or Re and L a ligand of the general formula (II) B-CO-CR1R2-A-CR3R4-CO-D(II) These new, bifunctional chelating agents with intermittent chalcogen atoms and their coupling products with compounds that accumulate specifically are suited for producing radiopharmaceuticals for diagnostic and therapeutic purposes.
Patent AU-581354-B2 (AU)
Title: Multi-ratio power transmission
Inventor: POLAK JAMES CASIMIR
IPC: F16H3/16
Filed: 1986-11-26
Granted: 1989-02-16
Abstract: A preselected multi-ratio power transmission has three friction clutches (l6,l8,20) and one mechanical synchroniser clutch assembly (34) to provide five forward speed ratios, and an additional mechanical clutch assembly (48) to provide a reverse ratio. The clutches are combined with a gearing arrangement (22,24,26,28,30,38,40,44) such that either sequential shifting or skip-shifting is possible.
Patent AU-586724-B2 (AU)
Title: 1-phenyl-3-benzazepines
Inventor: BONDINELL WILLIAM EDWARD
IPC: C07D223/16
Filed: 1986-12-19
Granted: 1989-07-20
Abstract: Compounds of the formula (1): 
<CHEM>
 and pharmaceutically acceptable acid addition salts are described wherein R<1> is hydrogen, C1-C6 alkyl or C3-C5 alkenyl; R<2> is hydrogen, hydroxy, C1-C6 alkoxy, halogen, trifluoromethyl, C1-C6 alkyl, SOnC1-C6 alkyl, SOnCF3, SOnphenyl or SO2NR<6>R<7>; R<3> is hydrogen, C1-C6-alkyl or C1-C6 alkanoyl; R<4> is SOnR<5> or SO2NR<6>R<7>; n is 0, 1 or 2; R<5> is 
<CHEM>
 or trifluoromethyl; and R<6> and R<7> are hydrogen or C1-C6 alkyl. These compounds are useful in the treatment of gastrointestinal motility disorders. Pharmaceutical compositions and methods of use are described. Intermediates and processes for the preparation of compounds of the formula (1) are described.